Analysis originally distributed on January 4, 2017 By: Michael Vodicka of Cannabis Stock Trades
Cannabis stocks had a ridiculous year in 2016.
The MJIC North American Cannabis Stock Index was up 208%. Take a look below.
Chart courtesy of MarijuanaIndex.com
Congratulations to the smart people who invested. Your portfolio had a great year.
Looking forward, I am expecting more of the same in 2017. Continue reading "North American Cannabis Stock Index up 208% in 2016"
Analysis originally distributed on December 14, 2016 By: Michael Vodicka of Cannabis Stock Trades
Back in 1991, very few people had heard of a company called Starbucks.
After all, what kind of fool would pay more than $2 for a cup of coffee? Particularly when you could brew a cup at home.
Today, Starbucks is a billion-dollar global leader and one of the most recognized consumer brands in the world. Early investors have been rewarded with life-changing gains.
Shares are up almost 17,000% in the last 25 years. Investing $10,000 at the IPO in 1991 would be worth $1.7 million today. $25,000 would have grown into $4.4 million. Take a look at the big gains below. Continue reading "4 Cannabis Stocks With The Best Chance To Be The Next Starbucks"
Analysis originally distributed on Decemberber 7, 2016 By: Michael Vodicka of Cannabis Stock Trades
Two of my favorite cannabis stocks reported great news.
On December 1 Canopy Growth Corp (TSX:CGC), Canada’s largest medical marijuana company, announced a $430 million bid to purchase industry rival Metrum (TSX.V:MT).
This is one of the most important events of the year in the cannabis industry.
If the merger is approved by regulators and shareholder it would the single largest merger in the history of the young cannabis industry.
It would help solidify Canopy’s status as the giant of the Canadian medical marijuana market.
The combined company would have a market cap of more than $1 billion, 655,000 thousand square feet of annual production capacity and the potential to capture half the entire Canadian medical marijuana. Continue reading "Canopy Positioned to Dominate with $430 Million Bid for Mettrum"
Analysis originally distributed on November 30, 2016 By: Michael Vodicka of Cannabis Stock Trades
While Cyber Monday and Black Friday did deliver solid sales growth, the cannabis industry was on a totally different level.
Joe Milton is the CEO of Baker, a cannabis industry software platform that connects dispensaries and customers with ordering systems, loyalty programs and message services. Baker operates in 175 dispensaries in seven U.S. states and Ontario.
In an interview with online publisher Westword, Milton reported huge sales gains across its network of users over the holidays.
From “Dispensaries Break Online Sales Records on Cyber Monday After a Very Green Friday” via Westword.
“Cyber Monday sales were up 70% from a ‘regular day’ while the average ticket price was up 230%.
According to Baker’s data, online orders went up 77 percent last week, when customers were using Baker’s loyalty program 65 percent more than they had in the previous two months.
On Black Friday, dispensaries across the state experienced almost twice the volume of a normal day.
Weed Wednesday saw 55 percent more orders than on a typical day and a 25 percent increase in the size of purchases, Milton notes. Baker also spotted a spike in concentrate sales.”
The spike in holiday sales is good news for the cannabis industry. Continue reading "Weed Wednesday Sales Growth Crushed Black Friday and Cyber Monday"
Analysis originally distributed on November 23, 2016 By: Michael Vodicka of Cannabis Stock Trades
If anyone thought investing in weed stock was going to be easy, this week was a reality check.
Cannabis stocks collided with two obstacles in the last week.
The first, four of the largest Canadian medical marijuana stocks were temporarily halted because of high levels of volatility.
For example, last Wednesday Canopy Growth Corp (CGC) was surging into a new all-time high above $17 – up more than 20% on the day.
While that was great news for shareholders, it set off the Toronto Stock Exchanges (TSE) circuit breaker. Shares were temporarily halted so the exchange engines wouldn’t melt down like a hunk of warm cheese.
Aphria (APH), the second-largest Canadian medical marijuana company, and Organigram (OGI), the third-largest Canadian medical marijuana company, were also halted last week after hitting new all-time highs.
The trading halts only lasted a few minutes at a time.
However, damage was inflicted. Continue reading "Cannabis Stocks Flashing Buy After Worst Week Of Year"
You are now leaving a Magnifi Communities’ website and are going to a website that is not operated by Magnifi Communities. This website is operated by Magnifi LLC, an SEC registered investment adviser affiliated with Magnifi Communities.
Magnifi Communities does not endorse this website, its sponsor, or any of the policies, activities, products, or services offered on the site. We are not responsible for the content or availability of linked site.
